重金属中毒治療薬の世界市場レポート2025年

重金属中毒治療薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5％で19億4,000万米ドルに成長します。予測期間の成長は、環境災害の発生増加、小児用重金属解毒治療に対する需要の高まり、新興市場への拡大、予防ヘルスケアプログラムへの重金属スクリーニングの組み込みに起因すると考えられます。この期間に予想される主な動向には、ナノ粒子ベースのドラッグデリバリーシステムの使用、選択性が強化され毒性が低減されたキレート剤の開発、解毒のための遺伝子編集とRNA療法の応用、治療計画を個別化するための人工知能（AI）の統合、重金属のリアルタイム検出とモニタリングのためのバイオセンサー技術の進歩などがあります。

工業化の進展は、今後数年間の重金属中毒治療薬市場の成長を促進すると予想されます。工業化とは、農業中心の経済から商品やサービスの製造を中心とする経済への移行を指します。この動向は、急速な都市開発とインフラの拡大によって促進され、ビジネスの成長と経済の発展に有利な条件を作り出しています。重金属中毒治療薬は、労働者の健康を守り、有害物質への暴露リスクを最小限に抑え、安全規制の遵守をサポートすることで、工業化に貢献し、最終的に生産性と職場の安全性を高めます。例えば、2024年9月、英国の政府機関である国家統計局によると、2023年の英国メーカーの製品売上総額は5,746億米ドル（4,561億英ポンド）に達し、2022年の5,532億米ドル（4,389億英ポンド）から約217億米ドル（172億英ポンド）、3.9％増加しました。このように、産業化の進展が重金属中毒治療薬市場を前進させています。

重金属中毒治療薬市場の主要企業は、治療効果の向上、副作用の最小化、有害金属への環境・職業暴露率の増加に対処するため、鉛中毒の解毒剤などの革新的治療法の開発に注力しています。これらの解毒剤は、典型的にはキレート剤であり、血流中の鉛と結合し、尿からの排泄を促進することで機能します。例えば、2023年8月、米国の製薬会社ライジング・ファーマシューティカルズは、小児および成人の鉛中毒の治療に使用される解毒剤、エデト酸カルシウム二ナトリウム注射剤を発表しました。この注射用キレート剤は、血液中および組織中の鉛濃度を下げる効果があり、鉛脳症のような重症例の治療には特に不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の重金属中毒治療薬：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の重金属中毒治療薬市場：成長率分析
• 世界の重金属中毒治療薬市場の実績：規模と成長, 2019-2024
• 世界の重金属中毒治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の重金属中毒治療薬：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の重金属中毒治療薬市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ALN-TMP
• デフェラシロクス
• デフェロキサミンメシル酸塩
• エメラミド
• その他の製品タイプ
• 世界の重金属中毒治療薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒ素の毒性
• クロムの毒性
• 銅の毒性
• 鉛の毒性
• その他の用途
• 世界の重金属中毒治療薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 在宅ヘルスケア
• 中毒情報センター
• 世界の重金属中毒治療薬市場ALN-TMPのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低分子干渉RNA（siRNA）を用いたキレート療法
• 標的RNA干渉メカニズム
• 静脈内製剤
• 肝臓鉄過剰症の応用
• 世界の重金属中毒治療薬市場デフェラシロックスのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口錠剤製剤
• 分散錠（DT）
• ジェネリックデフェラシロックス製品
• 輸血による鉄過剰症
• ベータサラセミア関連の使用
• 世界の重金属中毒治療薬市場デフェロキサミンメシル酸塩の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 筋肉内注射
• 皮下輸液ポンプ
• 鉄中毒緊急キット
• 透析患者におけるアルミニウム中毒
• 小児用および成人用製剤
• 世界の重金属中毒治療薬市場エメラミドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 水銀特異的キレート化
• 経口カプセル剤
• 親油性キレート剤
• 環境毒性物質暴露アプリケーション
• 治験薬
• 世界の重金属中毒治療薬市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジメルカプロール（BAL）
• ジメルカプトコハク酸（DMSA）
• 2,3-ジメルカプト-1-プロパンスルホン酸（DMPS）
• ペニシラミン
• エチレンジアミン四酢酸二ナトリウムカルシウム（EDTA）

第7章 地域別・国別分析

• 世界の重金属中毒治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の重金属中毒治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 重金属中毒治療薬市場：競合情勢
• 重金属中毒治療薬市場：企業プロファイル
  • Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Aurobindo Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Hikma Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • Lupin Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Zydus Cadila
• Aristo Pharmaceuticals Pvt. Ltd.
• Medopharm Pvt. Ltd.
• Cayman Chemical
• Recordati Rare Diseases Inc.
• Midas Pharma GmbH
• EmeraMed Limited
• Ambrosia Remedies Pvt. Ltd.
• SGPharma Pvt. Ltd.
• Nouryon
• Actavis Pharma
• Captura Biopharma
• Hope Pharmaceuticals
• HOPO Therapeutics Inc.
• Triveni Interchem Pvt. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 重金属中毒治療薬市場2029：新たな機会を提供する国
• 重金属中毒治療薬市場2029：新たな機会を提供するセグメント
• 重金属中毒治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Heavy metal poisoning drugs are chelating agents that treat toxicity caused by metals like lead, mercury, arsenic, and cadmium. These drugs bind to harmful metals in the bloodstream, forming complexes that the body can safely eliminate through urine or feces. Their primary purpose is to lower metal levels in the body and prevent damage to organs.

The main products in this category include ALN-TMP, deferasirox, deferoxamine mesylate, emeramide, and others. ALN-TMP is an experimental RNA interference (RNAi) therapy aimed at reducing the production of specific proteins involved in heavy metal metabolism. It is applied in cases of arsenic, chromium, copper, lead toxicity, among others, and is utilized by hospitals, clinics, home healthcare providers, and poison control centers.

The heavy metal poisoning drugs market research report is one of a series of new reports from The Business Research Company that provides heavy metal poisoning drugs market statistics, including heavy metal poisoning drugs industry global market size, regional shares, competitors with a heavy metal poisoning drugs market share, detailed heavy metal poisoning drugs market segments, market trends and opportunities, and any further data you may need to thrive in the heavy metal poisoning drugs industry. This heavy metal poisoning drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The heavy metal poisoning drugs market size has grown strongly in recent years. It will grow from $1.34 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period can be attributed to increased industrial pollution, higher occupational exposure in the mining and manufacturing sectors, greater awareness and diagnosis of heavy metal toxicity, expanded use of chelation therapy, and the implementation of government regulations focused on environmental and workplace safety.

The heavy metal poisoning drugs market size is expected to see strong growth in the next few years. It will grow to $1.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to the increasing occurrence of environmental disasters, rising demand for pediatric heavy metal detoxification treatments, expansion into emerging markets, and the incorporation of heavy metal screening into preventive healthcare programs. Key trends anticipated during this period include the use of nanoparticle-based drug delivery systems, development of chelators with enhanced selectivity and reduced toxicity, application of gene editing and RNA therapies for detoxification, integration of artificial intelligence (AI) to personalize treatment plans, and advancements in biosensor technology for real-time detection and monitoring of heavy metals.

The rising industrialization is anticipated to drive the growth of the heavy metal poisoning drugs market in the coming years. Industrialization refers to the transition of an economy from being primarily agricultural to one centered around the manufacturing of goods and services. This trend is fueled by rapid urban development and infrastructure expansion, which create favorable conditions for business growth and economic advancement. Heavy metal poisoning drugs contribute to industrialization by safeguarding workers' health, minimizing toxic exposure risks, and supporting compliance with safety regulations-ultimately enhancing productivity and workplace safety. For example, in September 2024, the Office for National Statistics, a UK-based government agency, reported that the total value of UK manufacturers' product sales reached $574.6 billion (£456.1 billion) in 2023, an increase of approximately $21.7 billion (£17.2 billion), or 3.9%, from $553.2 billion (£438.9 billion) in 2022. Thus, the growing industrialization is propelling the heavy metal poisoning drugs market forward.

Leading companies in the heavy metal poisoning drugs market are concentrating on the development of innovative treatments, such as antidotes for lead poisoning, to improve therapeutic effectiveness, minimize side effects, and address the growing rates of environmental and occupational exposure to toxic metals. These antidotes, typically chelating agents, work by binding to lead in the bloodstream and facilitating its excretion through urine. For example, in August 2023, Rising Pharmaceuticals, a US-based pharmaceutical firm, introduced edetate calcium disodium injection, an antidote used to treat lead poisoning in both children and adults. This injectable chelating agent is effective in lowering lead levels in the blood and tissues and is particularly vital for treating severe cases like lead encephalopathy.

In October 2024, the Biomedical Advanced Research and Development Authority (BARDA), a U.S.-based research agency, partnered with HOPO Therapeutics to support the development of an oral chelating agent for treating heavy metal poisoning. The goal of this collaboration is to advance HOPO-101 toward approval by the Food and Drug Administration (FDA) as an oral countermeasure for both radioactive and heavy metal exposure, thereby strengthening preparedness for radiological emergencies and addressing broader public health concerns such as lead poisoning. HOPO Therapeutics is a U.S.-based clinical-stage pharmaceutical company focused on developing best-in-class, orally available therapies for heavy metal toxicity.

Major players in the heavy metal poisoning drugs market are Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals, Lupin Pharmaceuticals Inc., Zydus Cadila, Aristo Pharmaceuticals Pvt. Ltd., Medopharm Pvt. Ltd., Cayman Chemical, Recordati Rare Diseases Inc., Midas Pharma GmbH, EmeraMed Limited, Ambrosia Remedies Pvt. Ltd., SGPharma Pvt. Ltd., Nouryon, Actavis Pharma, Captura Biopharma, Hope Pharmaceuticals, HOPO Therapeutics Inc., and Triveni Interchem Pvt. Ltd.

North America was the largest region in the heavy metal poisoning drugs market in 2024. The regions covered in heavy metal poisoning drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the heavy metal poisoning drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The heavy metal poisoning drugs market consists of sales of dithiol chelating agents, aminopolycarboxylic acid chelators, amino acid-derived chelators, and hydroxamic acid derivatives. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Heavy Metal Poisoning Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on heavy metal poisoning drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for heavy metal poisoning drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The heavy metal poisoning drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: ALN-TMP; Deferasirox; Deferoxamine Mesylate; Emeramide; Other Product Types
• 2) By Application: Arsenic Toxicity; Chromium Toxicity; Copper Toxicity; Lead Toxicity; Other Applications
• 3) By End-User: Hospitals; Clinics; Home Healthcare; Poison Control Centers
• Subsegments:
• 1) By ALN-TMP: Small Interfering RNA (siRNA)-Based Chelation Therapies; Targeted RNA Interference Mechanisms; Intravenous Formulations; Hepatic Iron Overload Applications
• 2) By Deferasirox: Oral Tablet Formulations; Dispersible Tablets (DT); Generic Deferasirox Products; Iron Overload From Blood Transfusions; Beta-Thalassemia Related Use
• 3) By Deferoxamine Mesylate: Intramuscular Injections; Subcutaneous Infusion Pumps; Iron Poisoning Emergency Kits; Aluminum Toxicity In Dialysis Patients; Pediatric And Adult Formulations
• 4) By Emeramide: Mercury-Specific Chelation; Oral Capsule Form; Lipophilic Chelators; Environmental Toxic Exposure Applications; Investigational Therapies
• 5) By Other Product Types: Dimercaprol (BAL); Dimercaptosuccinic Acid (DMSA); 2,3-Dimercapto-1-Propanesulfonic Acid (DMPS); Penicillamine; Calcium Disodium Ethylenediaminetetraacetate (EDTA)
• Companies Mentioned: Sun Pharmaceutical Industries Ltd.; Aurobindo Pharma Ltd.; Dr. Reddy's Laboratories Ltd.; Hikma Pharmaceuticals; Lupin Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Heavy Metal Poisoning Drugs Market Characteristics

3. Heavy Metal Poisoning Drugs Market Trends And Strategies

4. Heavy Metal Poisoning Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Heavy Metal Poisoning Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Heavy Metal Poisoning Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Heavy Metal Poisoning Drugs Market Growth Rate Analysis
• 5.4. Global Heavy Metal Poisoning Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Heavy Metal Poisoning Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Heavy Metal Poisoning Drugs Total Addressable Market (TAM)

6. Heavy Metal Poisoning Drugs Market Segmentation

• 6.1. Global Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ALN-TMP
• Deferasirox
• Deferoxamine Mesylate
• Emeramide
• Other Product Types
• 6.2. Global Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Arsenic Toxicity
• Chromium Toxicity
• Copper Toxicity
• Lead Toxicity
• Other Applications
• 6.3. Global Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Healthcare
• Poison Control Centers
• 6.4. Global Heavy Metal Poisoning Drugs Market, Sub-Segmentation Of ALN-TMP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Interfering RNA (siRNA)-Based Chelation Therapies
• Targeted RNA Interference Mechanisms
• Intravenous Formulations
• Hepatic Iron Overload Applications
• 6.5. Global Heavy Metal Poisoning Drugs Market, Sub-Segmentation Of Deferasirox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tablet Formulations
• Dispersible Tablets (DT)
• Generic Deferasirox Products
• Iron Overload From Blood Transfusions
• Beta-Thalassemia Related Use
• 6.6. Global Heavy Metal Poisoning Drugs Market, Sub-Segmentation Of Deferoxamine Mesylate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intramuscular Injections
• Subcutaneous Infusion Pumps
• Iron Poisoning Emergency Kits
• Aluminum Toxicity In Dialysis Patients
• Pediatric And Adult Formulations
• 6.7. Global Heavy Metal Poisoning Drugs Market, Sub-Segmentation Of Emeramide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mercury-Specific Chelation
• Oral Capsule Form
• Lipophilic Chelators
• Environmental Toxic Exposure Applications
• Investigational Therapies
• 6.8. Global Heavy Metal Poisoning Drugs Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dimercaprol (BAL)
• Dimercaptosuccinic Acid (DMSA)
• 2,3-Dimercapto-1-Propanesulfonic Acid (DMPS)
• Penicillamine
• Calcium Disodium Ethylenediaminetetraacetate (EDTA)

7. Heavy Metal Poisoning Drugs Market Regional And Country Analysis

• 7.1. Global Heavy Metal Poisoning Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Heavy Metal Poisoning Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Heavy Metal Poisoning Drugs Market

• 8.1. Asia-Pacific Heavy Metal Poisoning Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Heavy Metal Poisoning Drugs Market

• 9.1. China Heavy Metal Poisoning Drugs Market Overview
• 9.2. China Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Heavy Metal Poisoning Drugs Market

• 10.1. India Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Heavy Metal Poisoning Drugs Market

• 11.1. Japan Heavy Metal Poisoning Drugs Market Overview
• 11.2. Japan Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Heavy Metal Poisoning Drugs Market

• 12.1. Australia Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Heavy Metal Poisoning Drugs Market

• 13.1. Indonesia Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Heavy Metal Poisoning Drugs Market

• 14.1. South Korea Heavy Metal Poisoning Drugs Market Overview
• 14.2. South Korea Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Heavy Metal Poisoning Drugs Market

• 15.1. Western Europe Heavy Metal Poisoning Drugs Market Overview
• 15.2. Western Europe Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Heavy Metal Poisoning Drugs Market

• 16.1. UK Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Heavy Metal Poisoning Drugs Market

• 17.1. Germany Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Heavy Metal Poisoning Drugs Market

• 18.1. France Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Heavy Metal Poisoning Drugs Market

• 19.1. Italy Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Heavy Metal Poisoning Drugs Market

• 20.1. Spain Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Heavy Metal Poisoning Drugs Market

• 21.1. Eastern Europe Heavy Metal Poisoning Drugs Market Overview
• 21.2. Eastern Europe Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Heavy Metal Poisoning Drugs Market

• 22.1. Russia Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Heavy Metal Poisoning Drugs Market

• 23.1. North America Heavy Metal Poisoning Drugs Market Overview
• 23.2. North America Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Heavy Metal Poisoning Drugs Market

• 24.1. USA Heavy Metal Poisoning Drugs Market Overview
• 24.2. USA Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Heavy Metal Poisoning Drugs Market

• 25.1. Canada Heavy Metal Poisoning Drugs Market Overview
• 25.2. Canada Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Heavy Metal Poisoning Drugs Market

• 26.1. South America Heavy Metal Poisoning Drugs Market Overview
• 26.2. South America Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Heavy Metal Poisoning Drugs Market

• 27.1. Brazil Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Heavy Metal Poisoning Drugs Market

• 28.1. Middle East Heavy Metal Poisoning Drugs Market Overview
• 28.2. Middle East Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Heavy Metal Poisoning Drugs Market

• 29.1. Africa Heavy Metal Poisoning Drugs Market Overview
• 29.2. Africa Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Heavy Metal Poisoning Drugs Market Competitive Landscape And Company Profiles

• 30.1. Heavy Metal Poisoning Drugs Market Competitive Landscape
• 30.2. Heavy Metal Poisoning Drugs Market Company Profiles
  • 30.2.1. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aurobindo Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Hikma Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lupin Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Heavy Metal Poisoning Drugs Market Other Major And Innovative Companies

• 31.1. Zydus Cadila
• 31.2. Aristo Pharmaceuticals Pvt. Ltd.
• 31.3. Medopharm Pvt. Ltd.
• 31.4. Cayman Chemical
• 31.5. Recordati Rare Diseases Inc.
• 31.6. Midas Pharma GmbH
• 31.7. EmeraMed Limited
• 31.8. Ambrosia Remedies Pvt. Ltd.
• 31.9. SGPharma Pvt. Ltd.
• 31.10. Nouryon
• 31.11. Actavis Pharma
• 31.12. Captura Biopharma
• 31.13. Hope Pharmaceuticals
• 31.14. HOPO Therapeutics Inc.
• 31.15. Triveni Interchem Pvt. Ltd.

32. Global Heavy Metal Poisoning Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Heavy Metal Poisoning Drugs Market

34. Recent Developments In The Heavy Metal Poisoning Drugs Market

35. Heavy Metal Poisoning Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Heavy Metal Poisoning Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Heavy Metal Poisoning Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Heavy Metal Poisoning Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer